CV Therapeutics Offers $13.5M In Settlement Agreement
The settlement is part of a preliminary agreement reached by CV Therapeutics Inc. and stock holders who claimed that the company artificially inflated the price of its stock in August 2003.
The SEC filing also revealed that CV Therapeutics’ insurers will pay the court-approved fees of the plaintiffs' counsel.
This settlement was reached by CV...
To view the full article, register now.